IBS Price Prediction IBS

As of 25 August 2026, IBS (IBS) is trading at $12.4731.

24h move: -1.40%  |  Market cap: $9.23M  |  24h volume: $1.11M

Data is sourced from the CoinMarketCap API. Not investment advice.

IBS (IBS) is trading at $12.4731 as of 25 August 2026. With a market cap of $9.23M, IBS currently sits in the micro-cap segment of the crypto market. The coin moved -1.40% over the last 24 hours. Reported 24-hour volume is $1.11M.

IBS is sending mixed signals right now. The next directional move will likely depend on Bitcoin sentiment, liquidity conditions, and any fresh news tied to the project.

• The coin is down -1.40% in the last 24 hours, which may reflect early profit-taking, thin order books, or a sharp price-discovery phase after listing.
• The volume-to-market-cap ratio is 12.01%, a useful signal for judging whether liquidity is strong enough to support sustainable moves.
• Bitcoin direction and overall risk appetite still shape how aggressively traders treat smaller altcoins like IBS.
• Exchange listings, roadmap updates, and token-related news can quickly change the narrative for a fresh listing.

IBS is still in a fragile phase. A lower price does not automatically make a fresh listing attractive, especially if liquidity is thin or the project has not yet proven real traction.

Micro-cap assets can behave very differently depending on liquidity and market mood.

Short Term (1-4 Weeks)

In the short term, the main drivers are market sentiment, liquidity, and whether the first wave of buying interest holds up. Current momentum is weak, so the next bounce likely needs a stronger catalyst.

Medium Term (1-3 Months)

Over the next one to three months, adoption signals such as exchange support, community growth, and ecosystem activity will matter more than the initial listing spike. The current market cap stands at $9.23M.

Long Term (6-12 Months+)

Longer term, IBS will need sustainable product demand, ongoing development, and a credible roadmap to justify lasting upside. It first appeared in our listings on 09.05.2026.

IBS is a newly listed micro-cap asset, which places it in the highest-risk category. Only investors who fully understand the risks of fresh listings — including rug pulls, low liquidity, and extreme volatility — should consider a position, and only with capital they can afford to lose entirely.